Trial Profile
Using Allopregnanolone to Probe Behavioral and Neurobiological Mechanisms That Underlie Depression in Women During the Perimenopause
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 11 Nov 2022
Price :
$35
*
At a glance
- Drugs Brexanolone (Primary)
- Indications Depression
- Focus Therapeutic Use
- 08 Nov 2022 Status changed from not yet recruiting to recruiting.
- 18 Jul 2022 Planned initiation date changed from 1 Jun 2022 to 1 Sep 2022.
- 20 Apr 2022 New trial record